hMPV preF (site III) Specific Neutra™ Antibody (V3S-0124-XY3), Human IgG (CAT#: V3S-0124-XY3)

Send Inquiry
  • fig1

Datasheet

MSDS

COA

Summary
Property
Applications
Protocols
Target

Summary

Description The antibody is a neutralizing antibody against hMPV F protein. It binds conserved surfaces within sites III of hMPV F protein. It potently neutralized multiple hMPV and it also has cross-reactivity against RSV. This product can be used for Enzyme-linked immunosorbent assay, Bio-layer interferometry and Neutralization assay.
Clonality Monoclonal
Host Species Human
Target Species hMPV
Cross Reactivity hRSV-A1, hMPV-A2
Epitope Conserved surfaces within sites III.
Neutralization Mechanism It binds conserved surfaces within sites III of hMPV F protein.
IC50 28 ng/mL (hMPV-A1), 11 ng/mL(hMPV-A2), 22 ng/mL (hMPV-B1), 110 ng/mL (hMPV-B2)
Affinity KD = 64.8 nM (hMPV-A1)
Isotype IgG

Property

Expression Species HEK293F or CHO cell
Purity >95%, determined by SDS-PAGE and SEC-HPLC
Endotoxin <1 EU/mg
Form Liquid
Purification Protein A purified
Sterility 0.2 μM filtered
Formulation PBS, pH 7.4
Preservation No preservatives
Stabilizer No stabilizers
Storage Store at 4°C within one or two weeks. Store at -20°C for long term. Avoid repeated freeze/thaw cycles. Refer to the COA file for specifics.

Applications

Application ELISA; BLI; Neut
Application Notes Bio-layer interferometry (BLI): The KD of this antibody against hMPV F protein is 54 nM.

Protocols

ELISA Enzyme-Linked Immunosorbent Assay Protocol
WB Western Blot Protocol
FC Flow Cytometry Protocol

Target

Target hMPV preF
Alternative Name Human metapneumovirus fusion glycoprotein; preF; fusion (F) protein; pre-fusion; hMPV
Research Area Infectious Disease
Related Disease Respiratory disease
For research use only, not directly for clinical use.
banner banner
© 2024 Creative Biolabs. All Rights Reserved.
antibody
Online Inquiry